Home/Investors/Ysios Capital

Ysios Capital

Biotech Investor · 8 portfolio companies

Portfolio

8

Focus Areas

13

Top Stage

Phase 2

Investment Focus

Hematology Neuroscience Psychiatry Metabolic Disease Obesity Type 2 Diabetes Inflammatory Bowel Disease Oncology Infectious Diseases Ophthalmology Genetic Diseases Reproductive Medicine Women's Health

Portfolio Companies

Company	Stage	Valuation	Focus
VarmX	phase-2	—	Hematology
Kynexis	phase-2	—	Neuroscience, Psychiatry
Cytoki Pharma	Phase 2	—	Metabolic Disease, Obesity
ISA Pharmaceuticals	Phase 2	—	Oncology, Infectious Diseases
SpliceBio	Phase 1	—	Ophthalmology, Genetic Diseases
ReproNovo	Phase 2	—	Reproductive Medicine, Women's Health
Synendos Therapeutics	Phase 1	—	Psychiatry, Neuroscience
Tagworks Pharmaceuticals	Phase 1	—	Oncology

Frequent Co-Investors

Gimv2 shared Forbion2 shared Novartis Venture Fund2 shared M Ventures2 shared Gilde Healthcare2 shared Seventure Partners1 shared Innovation Quarter1 shared BioGeneration Ventures1 shared